OVERVIEW. FEMM (Fertility Education & Medical Management) is headquartered in New York City, NY. 1

Similar documents
Abnormal Uterine Bleeding Case Studies

Dr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO

Overview of Reproductive Endocrinology

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)

Reproductive Testing: Less is More G. Wright Bates, Jr., M.D. Professor and Director Reproductive Endocrinology and Infertility Objectives

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

Reproductive Health and Pituitary Disease

12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman

PCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS

FERTILITY & TCM. On line course provided by. Taught by Clara Cohen

Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital

Reproductive Hormones

CASE 41. What is the pathophysiologic cause of her amenorrhea? Which cells in the ovary secrete estrogen?

Case Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation

One Day Hormone Check

Sexual dysfunction of chronic kidney disease. Razieh salehian.md psychiatrist

Timing is everything. Ovulation Tracking. 3 Cycles bulk-billed

Polycystic Ovary Syndrome

Infertility for the Primary Care Provider

Women, Hormones & The Menstrual Cycle: Herbal & Medical Solutions From Adolescence To Menopause By Ruth Trickey READ ONLINE

WHY INVESTIGATE FOR INFERTILITY

POTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL. Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist

9.4 Regulating the Reproductive System

HORMONES & REPRODUCTION OUTLINE

Hormone Balance - Female Report SAMPLE. result graph based on Luteal Phase. result graph based on Luteal Phase

Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary

When you lose sleep in a regular basis, it is very difficult to catch up. Sleep is a very important mechanism that your body uses to recuperate.

Hormonal Control of Human Reproduction

What is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this...

Polycystic Ovary Syndrome: Cardiovascular Disease risk

PCOS IN ADOLESCENTS: EARLY DETECTION AND INTERVENTION

Polycystic Ovarian Syndrome (PCOS) LOGO

Test Briefing on Hormonal Disorders and Infertility

Ohio Northern University HealthWise. Authors: Alexis Dolin, Andrew Duska, Hannah Lamb, Eric Miller, Pharm D Candidates 2018 May 2018

Reproduction and Development. Female Reproductive System

Timing is everything. Ovulation Tracking. 3 Cycles no out-of-pocket* Patient Information Booklet

One Day Hormone Check

Topics. Periods Menopause & HRT Contraception Vulva problems

Therapeutic Cohort Results

The Science of your Cycle

SAMPLE REPORT. Order Number: PATIENT. Age: 40 Sex: F MRN:

Polycystic Ovary Syndrome

Therapeutic Cohort Results

AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE

Infertility History Form

The Science Behind Natural Family Planning

lactotrophs 120 min- FSH 60 min- LH Hypothalamus GnRH pituitary Estradiol +/- Progesterone _ FSH L H Ovary Uterus Ovulation Antral follicle >2mm

Reproductive Endocrinology and Infertility Rotation Objectives. Reproductive Endocrinology and Infertility Specialists

Polycystic Ovary Syndrome

From the editors desk

Therapeutic Cohort Results

Hyperandrogenism. Dr Jack Biko. MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany)

What are the main functions of the male reproductive system? 1. Produce sperm 2. Deposit sperm into the female 3. Provide a pathway for the removal

Test Results SB Samples Arrived: 01/15/2014 Samples Collected: Saliva: 01/11/14 07:14 Date Closed: 01/18/2014

Polycystic ovary syndrome

Physiology of Male Reproductive System

Approach to ovulation induction and superovulation in women with a history of infertility. Anatte E. Karmon, MD

12/27/2013. Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND

PERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW.

ASPEN MOUNTAIN MEDICAL CENTER. Lab Health Fair

Female Reproductive System. Lesson 10

Polycystic Ovary Syndrome Therapy Dr. Pilar Vigil MD, PhD, FACOG

INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview

Causes of Infertility and Treatment Options

FLASH CARDS. Kalat s Book Chapter 11 Alphabetical

On Diseases Of Menstruation And Ovarian READ ONLINE

Achieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

HCG (human chorionic gonadotropin); Novarel Pregnyl (chorionic gonadotropin); Ovidrel (choriogonadotropin alfa)

N. Shirazian, MD. Endocrinologist

Estrogen Dominant Conditions Part I

Polycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology

Research Article. Comparative analysis of Yoga and clomiphene in infertile women. Richa Sharma 1, Himsweta Shrivastava 1, Arvind Kumar 2

GONADAL FUNCTION: An Overview

Outline OVERVIEW PUBERTY PRE-TESTS PUBERTY WITH SAM AND SALLY MENSTRUATION: HOW DOES IT WORK? SPERMATOGENESIS: HOW DOES IT WORK?

International Academy of Engineering and Medical Research, 2018 Volume-3, Issue-1 Published Online January 2018 in IAEMR (

Evaluation of the Infertile Couple

Case. 24 year old female presented to your office complaining of excess hair growth on her face and abdomen. Questions?

Infertility: A Generalist s Perspective

INFERTILITY CAUSES. Basic evaluation of the female

Dr Catherine Black. Head of WOOMB NZ

Frequency of menses. Duration of menses 3 days to 7 days. Flow/amount of menses Average blood loss with menstruation is 60-80cc.

Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc)

Polycystic Ovary Syndrome (PCOS):

MULTIPLE CHOICE: match the term(s) or description with the appropriate letter of the structure.

Web Activity: Simulation Structures of the Female Reproductive System

EVALUATING THE INFERTILE PATIENT-COUPLES. Stephen Thorn, MD

New PCOS guidelines: What s relevant to general practice

Infertility Investigations. Patient Information

Hd Hydroxylase. Cholesterol. 17-OH Pregnenolne DHEA Andrstendiol. Pregnenolone. 17-OH Progestrone. Androstendione. Progestrone.

THE four SEASONS. OF THE FEMALE CYCLE Susan Hart

Top 5 Fertility Secrets Revealed

Female Hormones The Kalish Method Approach Dr. Dan Kalish

Dr Mary Birdsall. Fertility Associates Auckland

Reproductive physiology

SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY

Intrauterine Insemination - FAQs Q. How Does Pregnancy Occur?

1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH.

WEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH

Reproductive FSH. Analyte Information

Transcription:

OVERVIEW FEMM (Fertility Education & Medical Management) is headquartered in New York City, NY. 1 FEMM is a three-tiered women s healthcare project. Grounded in revolutionary, peer-reviewed research in women s endocrinology, developed through its research institute, the Reproductive Health Research Institute (RHRI), in Santiago, Chile, FEMM is designed to teach women and to train teachers and medical providers around the world to serve at the grassroots level. FEMM trains doctors and nurses to offer targeted reproductive education and medical management solutions within pre-existing clinics. FEMM provides the educational and medical training model, as well as expertise, research, and training support, for providers to maximize the care offered to women in their targeted patient populations. FEMM Education The FEMM Education program teaches women the link between hormones and health, and how to monitor observable hormonal biomarkers. Once women understand their bodies, they can identify normal or abnormal patterns of reproductive function, and seek medical support as informed participants in their own healthcare. Over time, FEMM can also be used as a form of family planning, per a couple s desire to achieve or avoid pregnancy, by applying rules to intercourse during the cycle especially around a woman s self-identified window of fertility. The need for hormonal health education Without knowledge about the hormonal interplay of her cycle, a woman s ability to make empowered, informed health decisions is hindered. Unfortunately, evidence shows that most women do not understand how their bodies work. They also lack health literacy, or awareness of the behaviors that affect their general and reproductive health over the course of their lives, such as exercise, sleep, weight, and nutrition. Women often experience shame and stigma surrounding menstruation, which also leads to poorer health outcomes. This startling reality evidences the need for the education that FEMM provides. A woman equipped with the knowledge to understand her body is empowered to make the health care and family planning decisions best for her. FEMM content: Understanding hormonal biomarkers FEMM details the hormonal activities that occur throughout a woman s cycle, so that she can observe and understand the signs of her hormonal fluctuations. There are three general phases of the cycle: pre-ovulatory, which begins at menstruation and is marked by low hormonal activi- 1 For more information about FEMM visit www.femmhealth.org. FEMM s white paper, The Case for FEMM, provides the scientific, legal, and policy foundations for its education and healthcare model.

ty; ovulatory, a time of significant and rapid hormonal change, which is also the time of fertility; and post-ovulatory, when rising progesterone is the dominant hormonal activity. The cycle ends when progesterone drops, leading to the shedding of the uterine lining (menstruation), and the start of a new cycle. The appropriate activity and interplay of these hormones throughout this process is crucial to a woman s health and well-being. This education series is offered over the course of four sessions, in-person and online, one-onone or in a group setting. Provision of classes depends on the infrastructure of the clinic into which the program is integrated. The FEMM Education sessions include: FEMM Intro (30 minutes): Participants are introduced to FEMM (Fertility Education & Medical Management) as a model for women s reproductive health. A woman s reproductive health is closely tied to the state of her general health and to the delicate interplay of certain hormones within her body. The sufficient production of these hormones can be tracked throughout each cycle, as indicators of both health and fertility. FEMM enables women to become informed participants in their own healthcare. (1) FEMM & Your Health (1 hour): Participants learn the parts and function of reproductive anatomy, and the physiology of ovulation understanding the critical role of hormones in the cycle. Hormones from the brain and ovaries affect the health of the reproductive organs and the entire body. Observable biomarkers allow women to identify hormonal changes, key cycle events such as ovulation and other indicators of health and fertility. Participants are taught the method of FEMM charting through observing and recording these biomarkers. The session concludes with charting exercises. (2) FEMM Expert (1.5 hours): Participants learn to understand the cycle both its biomarkers and the underlying hormonal activity as an indicator of their overall health. They are taught the phases of the cycle with an emphasis on the time of ovulation, the dominant hormonal activity in each phase, and what biomarker observations within each phase are necessary for a woman to be considered healthy. Attention is given to the understanding of the cycle as a holistic fertile process, which is fundamental to understanding cycle variations. The session includes analysis of various cycle types, including those of health concern. Exercises, Q&A, and case studies accompany this session. (3) FEMM Family Planning (1.5 hours): In this session, participants are taught the principles of FEMM Family Planning. The session includes a review of male and female reproductive physiology, the dominant reproductive hormones, and the key stages in and differences between male and female fertility throughout reproductive life. With family planning, the key event in a woman s cycle is ovulation, and so participants learn to relate cycle biomarkers to ovulation and a woman s fertility. Primary biomarkers are estrogenic cervical fluid and the surge of the luteinizing hormone (LH) just prior to ovulation. Participants apply this knowledge to identifying ovulation and fertility in variable cycle types. Exercises, Q&A, and case studies accompany this session. Independent 3-hour teenfemm and teenmen modules provide a targeted form of this education to middle and high school students with a specific focus on understanding the health- 2

hormone integration in the body, key physiological changes in puberty in both girls and boys, and the foundation for healthy sexual relationships. FEMM health applications Application #1: The importance of monitoring her cycle Monitoring her cycle allows a girl or woman to understand, maintain, and improve her health. She can learn to identify both regular and irregular activity and hormonal patterns. In fact, often the first sign of an underlying health problem a woman experiences is an abnormality in ovulation followed by irregular cycles. Cycle irregularities are associated with several poor health outcomes, such as coronary heart disease, Type 2 diabetes, and decreased fertility, so it is critical to identify and address irregularities promptly. Monitoring cycle irregularities can also be a diagnostic tool in determining underlying health problems. FEMM enables a woman to recognize irregularities and present evidence to health care professionals, who then use that evidence to diagnose and treat the underlying problem. This form of monitoring is especially important in pre-pubescent girls and girls entering puberty, as many ovarian dysfunctions develop and manifest during this stage of the reproductive continuum and never spontaneously resolve. Application #2: Achieving and avoiding pregnancy Because a woman can get pregnant only in the few days leading up to and the day of ovulation, and because her biomarkers are usually identifiable during this phase of her cycle, she can use her FEMM knowledge either to achieve or to avoid pregnancy. The importance of FEMM Informed choice: Making informed health and family planning decisions Informed choice is a central component of health care and family planning. Informed choice means making a health decision after learning about and considering all the options and information available. Women are often unable to make informed choices about their health and family planning decisions because they lack information about how certain methods work and what effects they might have on their health. FEMM informs women about the mechanism of action of each method, and the way that this relates to her long-term health outcomes. Integrating the health of families The hormone-health applications to FEMM impact the integration of healthy practices within an entire family on the mother, who is tasked with managing her health and fertility for the sake of her spouse and children, and then on those exact children, whose own hormonal development into and beyond puberty can be conditioned by lifestyle and home life as well as hormonal dysfunctions. Where an education in tracking hormonal biomarkers is provided to families, family participation in healthy decision-making increases for individual members of that family, alongside spousal commitment to family planning. 3

The FEMM Education program also empowers families to prioritize optimal health and life outcomes. In acquiring tools to manage daily health literacy, women within families can observe changes in their body, catch hormonal abnormalities as they arise, and then seek medical care that ensures maximum return to the families from which they come. As these health and fertility questions are settled in a manner ordered and healthy, committed, safe, stable, and healthy marriages can be ensured. Preventing risky behavior Due to the development of a girl s cervical ectopy, a layer of protection over her cervix that doesn t fully mature until her mid-twenties, girls between the ages of 15-24 are the most at-risk population in the USA for the acquisition of STDs. 2 The use of modern hormonal contraceptives delays their cervical maturation, increasing the risk of acquiring an infection. Early sexual debut as well as risky sexual behavior also contribute to increased risks of infection. In this context, targeted education to teens about the structure of their reproductive systems, as well as the integration of hormonal activity with the entire body to maximize health over a lifetime, lays the foundation for a preventative pedagogy that targets issues such early sexual debut and sexual violence. When women understand their bodies, as well as how behavioral or medical management choices impact their health and fertility, they acquire the necessary tools to order their experiences and choices in accord with standards for health. When men understand the basis of women s health and fertility, they too can order their choices in accord with standards for health as well as mutual respect. Students acquire a holistic foundation for understanding the benefits of delaying sex or returning to a sexually risk-free status. FEMM App 3 Figure 1 The FEMM app (see figure 1) was designed to help women track their health by observing key biomarkers such as cervical fluid, bleeding, physical symptoms like cramps and acne, and emo- 2 Centers for Disease Control & Prevention (CDC), Reported STDs in the United States, 2016, at https://www.cdc.gov/nchhstp/newsroom/docs/factsheets/std-trends-508.pdf. 3 For more information about the FEMM app, visit http://femmhealthapp.org/. 4

tional symptoms like depression, moodiness, etc. These biomarkers indicate the hormonal interplay that occurs throughout the cycle. The FEMM app can also assist in preventing or achieving pregnancy. Through charting with the FEMM app, women know the average length of their cycle, the quality and length of their bleeding, the point of ovulation at each cycle, their fertility window, and more. Currently available in English and Spanish, the app can be downloaded for free from the Android and Apple stores. As certain studies indicate that women do not have the tools to identify a scientifically-sound app for health and fertility literacy, the FEMM team continually assesses, updates, and expands the scientific basis and support for its app. FEMM Medical Management The FEMM Medical Management program offers medical care that diagnoses and treats the underlying causes of ovarian dysfunction, which manifests in symptoms such as cramps, acne, facial hair, migraines, and more; infertility; and menopausal conditions. Medical protocols draw on the most recent research in women's reproductive endocrinology. 4 Their diagnostic algorithm accounts for the way in which female reproductive activity evolves over an ovarian continuum, to distinguish between activity that is healthy, given a woman s reproductive stage, or activity that is an indicator of ovarian dysfunction. The most frequent causes of menstrual irregularities associated with ovulatory dysfunctions are hormonal abnormalities. These can be hypothalamic, pituitary, thyroid, adrenal, ovarian, and metabolic disorders. Often, healthcare providers have focused on regularizing bleeding patterns, without paying attention to ovulation in reproductive-age women. The fact that women have biomarkers that enable them to recognize ovulation, and hence which stage of the ovarian continuum they are in, allows them to evaluate their own health. Accordingly, normal ovulatory activity during reproductive years can be considered a sign of health, because it implies adequate endocrine and gonadal function. Women in conditions such as breastfeeding or pregnancy will also be able to identify their anovulatory state as part of the continuum. Periods of transition from anovulation to regular ovulation, such as those found during puberty and perimenopause, can also be identified as a physiological part of the continuum by women using their biomarkers. A key sign of an underlying health problem a woman may experience is an abnormality in ovulation followed by irregular cycles or amenorrhea. Indeed, when pregnancy, lactation, or menopause are not the causes, persistent irregularities in the ovulatory cycle can be associated with lifestyle, stress, and endocrine, gynecological, autoimmune, nutritional, genetic, and iatrogenic disorders. 4 For a summary of this research, review the FEMM white paper, The Case for FEMM, on the FEMM website (https://femmhealth.org/about-us/white-paper/) as well as up-to-date peer-reviewed research from the RHRI (https://femmhealth.org/research/publications/). 5

When a woman is equipped with the necessary tools to read her chart, as a foundation to personal health literacy, she can seek out medical care proportionate to the dysfunction manifested. Medical providers trained in the FEMM protocols are equipped to proceed with diagnosis and treatment proportionate to the need. These providers first run a basic hormonal profile (BHP) blood draw on each patient, to evaluate the activity of approximately a dozen key hormones (see figure 2). Where the BHP demands it, physicians return women for more targeted, functional tests to enable a more precise diagnosis. Then, in following the algorithm in the protocols to test against every single possible diagnosis, a provider can determine the originating hormonal disturbance in a woman s body a diagnosis entirely personalized to her condition. Treatment plans then integrate a three-pronged solution: exercise, diet, and medical care that ranges from immunological support to targeted pharmacological interventions. In the clinical context, therefore, FEMM aids the Figure 2 provision of the following services: preventative and core health education, which enables girls and women to recognize the health of their body and to order health-related decisions accordingly, per the sessions outlined above; family planning education, which enables couples to postpone, achieve, and facilitate the spacing of their children, per the sessions outlined above; medical care and protocols targeted to the diagnosis of treatment of underlying ovarian dysfunctions, aimed at both re-integrating hormonal activity and resolving symptoms (i.e., facial hair, acne, painful and irregular cycles, patterns of infertility and miscarriage, etc.), per the protocols and procedures outlined above; pregnancy tests; health screenings and exams, including for the diagnosis and treatment of STDs, breast cancer, and cervical cancer; and lab tests. All FEMM Education and Medical Management services are reimbursable with the correct insurance codes: CBC with diff: R53.83 (fatigue), N92.0 (menorrhagia) CMP: R53.83 (fatigue) 6

TSH: Z13.29 (thyroid disorder), R53.83 (fatigue), N92.0 (menorrhagia) Vitamin D 25-OH: E55.9 (vitamin D deficiency) Lipid panel: Z13.220 (screening for lipoid disorders) FSH: N91.2 (amenorrhea), N92.6 (irregular menses) Prolactin: N64.3 (galactorrhea) Cortisol: R53.83 (fatigue) DHEA-S: L68 (hirsutism), L70 (acne), E28.1 (androgen excess) Total testosterone: L68 (hirsutism), L70 (acne), E28.1 (androgen excess) SHBG: Z13.29 (thyroid disorder), R73.09 (abnormal glucose) 17 OH progesterone: L70 (acne) OGTTI: R73.09 (abnormal glucose), E28.2 (PCOS) Progesterone: N91.2 (amenorrhea) Estradiol: E28.2 (PCOS) Sexual & reproductive health education (FEMM Education, 1 hour): 99404 Where these services are integrated into clinical settings complying with the Title X statute, as well as the Title X program regulations, patients from low-income families with incomes that fall at or below 100% of the current Federal Poverty Guidelines (Federal Poverty Level, FPL) will not be charged for them except where third parties are authorized or legally obligated to pay. 7